Learn, Analyse & Invest
only with
only with
+91
Download Orca
iSERA Lifesciences Ltd.
iSERA Lifesciences
₹ 0.00
0.00 (0.00)%
NSE
BSE
Software & IT Services
Small-cap - With a market cap of ₹65.16 Cr.
| EX-Date | Purpose |
|---|---|
| 25 06 2021 | Audited Results |
| 14 08 2021 | Quarterly Results |
| 05 09 2021 | A.G.M. |
| 06 09 2021 | A.G.M. (Revised) |
| 15 11 2021 | Quarterly Results |
| 14 02 2022 | Quarterly Results |
| 30 05 2022 | Audited Results |
| 11 06 2022 | Preferential Issue of shares |
| 13 08 2022 | Quarterly Results |
| 05 09 2022 | A.G.M. |
| 14 11 2022 | Quarterly Results |
| 13 02 2023 | Quarterly Results |
| 29 05 2023 | Audited Results |
| 11 08 2023 | Quarterly Results |
| 05 09 2023 | A.G.M. |
| 10 11 2023 | Quarterly Results |
| 08 02 2024 | Quarterly Results |
| 13 11 2024 | Quarterly Results |
| 10 02 2025 | Quarterly Results |
| 30 05 2025 | Audited Results |
| 01 08 2025 | Quarterly Results |
| 03 10 2025 | Right Issue of Equity Shares & Inter-alia the proposal of fund raising by way of issue of equity shares or other securities of the Company through a rights issue and/or any other permissible mode, as may be permitted under applicable law, subject to such regulatory/statutory approvals as may be required and as may be deemed appropriate by the Company for its accelerated growth. |
| 09 10 2025 | Right Issue of Equity Shares |
| 13 11 2025 | Quarterly Results |
| 10 02 2026 | Quarterly Results |
| 20 04 2026 | Preferential Issue of shares |
News
